Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Inflammatory Bowel Diseases

  Free Subscription


18.10.2021

1 AJR Am J Roentgenol
6 Aliment Pharmacol Ther
1 Ann Intern Med
2 BMC Gastroenterol
1 Dig Dis Sci
3 Dis Colon Rectum
1 Gastroenterology
2 Inflamm Bowel Dis
11 J Crohns Colitis
1 PLoS One
1 Z Gastroenterol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AJR Am J Roentgenol

  1. PARODER V
    Editorial Comment: Continuously Expanding Impact of MRI in Management of Perianal Crohn Disease.
    AJR Am J Roentgenol. 2021 Oct 13. doi: 10.2214/AJR.21.26937.
    PubMed        


    Aliment Pharmacol Ther

  2. TAKENAKA K, Kawamoto A, Hibiya S, Suzuki K, et al
    Higher concentrations of cytokine blockers are needed to obtain small bowel mucosal healing during maintenance therapy in Crohn's disease.
    Aliment Pharmacol Ther. 2021;54:1052-1060.
    PubMed         Abstract available

  3. RUBIN DT, Modesto I, Vermeire S, Danese S, et al
    Worldwide post-marketing safety surveillance experience with tofacitinib in ulcerative colitis.
    Aliment Pharmacol Ther. 2021 Oct 9. doi: 10.1111/apt.16619.
    PubMed         Abstract available

  4. TAKENAKA K, Kawamoto A, Ohtsuka K
    Editorial: higher concentrations of cytokine blockers are needed to obtain small bowel mucosal healing during maintenance therapy in Crohn's disease-authors' reply.
    Aliment Pharmacol Ther. 2021;54:1087.
    PubMed        

  5. RAKOWSKY S, Cheifetz AS, Papamichael K
    Editorial: higher concentrations of cytokine blockers are needed to obtain small bowel mucosal healing during maintenance therapy in Crohn's disease.
    Aliment Pharmacol Ther. 2021;54:1085-1086.
    PubMed        

  6. JOLVING LR, Anru PL, Nielsen J, Friedman S, et al
    The risk of chronic diseases and congenital malformations during childhood and adolescence after in utero exposure to thiopurines.
    Aliment Pharmacol Ther. 2021;54:1061-1069.
    PubMed         Abstract available

  7. SAINZ E, Zabana Y, Miguel I, Fernandez-Clotet A, et al
    Clinical features, therapeutic requirements and evolution of patients with Crohn's disease and upper gastrointestinal involvement (CROHNEX study).
    Aliment Pharmacol Ther. 2021;54:1041-1051.
    PubMed         Abstract available


    Ann Intern Med

  8. MELMED GY, Botwin GJ, Sobhani K, Li D, et al
    Antibody Responses After SARS-CoV-2 mRNA Vaccination in Adults With Inflammatory Bowel Disease.
    Ann Intern Med. 2021 Oct 12. doi: 10.7326/M21-2483.
    PubMed        


    BMC Gastroenterol

  9. KASHIMA S, Moriichi K, Ando K, Ueno N, et al
    Development of pulmonary sarcoidosis in Crohn's disease patient under infliximab biosimilar treatment after long-term original infliximab treatment: a case report and literature review.
    BMC Gastroenterol. 2021;21:373.
    PubMed         Abstract available

  10. YUE B, Meng Y, Zhou Y, Zhao H, et al
    Characteristics of endoscopic and pathological findings of amebic colitis.
    BMC Gastroenterol. 2021;21:367.
    PubMed         Abstract available


    Dig Dis Sci

  11. XU F, Carlson SA, Liu Y, Greenlund KJ, et al
    Urban-Rural Differences in Health Care Utilization for Inflammatory Bowel Disease in the USA, 2017.
    Dig Dis Sci. 2021 Oct 11. pii: 10.1007/s10620-021-07264.
    PubMed         Abstract available


    Dis Colon Rectum

  12. PATEL M, Hedrick T
    Postoperative Evaluation and Management of Portomesenteric Venous Thrombosis in Patients with Inflammatory Bowel Disease.
    Dis Colon Rectum. 2021 Oct 11. pii: 00003453-900000000-99356.
    PubMed        

  13. CAVALLARO PM, Fearnhead NS, Bissett IP, Brar MS, et al
    Patients Undergoing Ileoanal Pouch Surgery Experience a Constellation of Symptoms and Consequences Representing a Unique Syndrome: A Report from the Patient-Reported Outcomes After Pouch Surgery (PROPS) Delphi Consensus Study.
    Dis Colon Rectum. 2021;64:861-870.
    PubMed         Abstract available

  14. KOTZE PG, Strong SA, Lightner AL
    Advances in Inflammatory Bowel Diseases 2020 Virtual: Key Take-Home Points.
    Dis Colon Rectum. 2021;64:774-776.
    PubMed        


    Gastroenterology

  15. SPIERA E, Agrawal M, Ungaro R
    COVID-19 mRNA Vaccine Short-Term Safety in Patients with Inflammatory Bowel Disease.
    Gastroenterology. 2021 Oct 6. pii: S0016-5085(21)03619.
    PubMed        


    Inflamm Bowel Dis

  16. ANNE SHAFER L, Shaffer S, Witt J, Nugent Z, et al
    IBD Disability Index Is Associated With Both Direct and Indirect Costs of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Oct 12. pii: 6390721. doi: 10.1093.
    PubMed         Abstract available

  17. REENAERS C, de Roover A, Kohnen L, Nachury M, et al
    Bariatric Surgery in Patients With Inflammatory Bowel Disease: A Case-Control Study from the GETAID.
    Inflamm Bowel Dis. 2021 Oct 12. pii: 6391132. doi: 10.1093.
    PubMed         Abstract available


    J Crohns Colitis

  18. SAEVIK F, Eriksen R, Eide GE, Gilja OH, et al
    Development and Validation of a Simple Ultrasound Activity Score for Crohn's Disease.
    J Crohns Colitis. 2021;15:115-124.
    PubMed         Abstract available

  19. ZOLLNER A, Schmiderer A, Reider SJ, Oberhuber G, et al
    Faecal Biomarkers in Inflammatory Bowel Diseases: Calprotectin Versus Lipocalin-2-a Comparative Study.
    J Crohns Colitis. 2021;15:43-54.
    PubMed         Abstract available

  20. DE CAMPOS RJDS, Lucchetti G, Lucchetti ALG, Chebli LA, et al
    Influence of Religiousness and Spirituality on Remission Rate, Mental Health, and Quality of Life of Patients With Active Crohn's Disease: A Longitudinal 2-Year Follow-up Study.
    J Crohns Colitis. 2021;15:55-63.
    PubMed         Abstract available

  21. WEWER MD, Zhao M, Nordholm-Carstensen A, Weimers P, et al
    The Incidence and Disease Course of Perianal Crohn's Disease: A Danish Nationwide Cohort Study, 1997-2015.
    J Crohns Colitis. 2021;15:5-13.
    PubMed         Abstract available

  22. THOMAS PWA, Ferwerda G, West RL, Hoentjen F, et al
    Immediate Infusion Reaction to Intravenous Ustekinumab in Three Crohn's Disease Patients: A Case Report and Review of the Literature.
    J Crohns Colitis. 2021;15:162-164.
    PubMed         Abstract available

  23. LEE S, Kuenzig ME, Ricciuto A, Zhang Z, et al
    Smoking May Reduce the Effectiveness of Anti-TNF Therapies to Induce Clinical Response and Remission in Crohn's Disease: A Systematic Review and Meta-analysis.
    J Crohns Colitis. 2021;15:74-87.
    PubMed         Abstract available

  24. EFFENBERGER M, Reider S, Waschina S, Bronowski C, et al
    Microbial Butyrate Synthesis Indicates Therapeutic Efficacy of Azathioprine in IBD Patients.
    J Crohns Colitis. 2021;15:88-98.
    PubMed         Abstract available

  25. ELFIKY AMI, Ghiboub M, Li Yim AYF, Hageman IL, et al
    Carboxylesterase-1 assisted targeting of HDAC inhibitors to mononuclear myeloid cells in Inflammatory Bowel Disease.
    J Crohns Colitis. 2021 Oct 11. pii: 6387695. doi: 10.1093.
    PubMed         Abstract available

  26. SPINELLI A, Bonovas S, Burisch J, Kucharzik T, et al
    ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment.
    J Crohns Colitis. 2021 Oct 12. pii: 6390023. doi: 10.1093.
    PubMed         Abstract available

  27. RAINE T, Bonovas S, Burisch J, Kucharzik T, et al
    ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment.
    J Crohns Colitis. 2021 Oct 12. pii: 6390052. doi: 10.1093.
    PubMed        

  28. D'AMICO F, Nancey S, Danese S, Peyrin-Biroulet L, et al
    A Practical Guide for Faecal Calprotectin Measurement: Myths and Realities.
    J Crohns Colitis. 2021;15:152-161.
    PubMed         Abstract available


    PLoS One

  29. TAO F, Xing X, Wu J, Jiang R, et al
    Enteral nutrition modulation with n-3 PUFAs directs microbiome and lipid metabolism in mice.
    PLoS One. 2021;16:e0248482.
    PubMed         Abstract available


    Z Gastroenterol

  30. SCHMIDT C, Bachmann O, Baumgart DC, Goetz M, et al
    [Position paper on endoscopic reporting in IBD].
    Z Gastroenterol. 2021;59:1091-1109.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: